Medtronic (MDT) May IV bid up into Q1 EPS and outlook

Go back to Medtronic (MDT) May IV bid up into Q1 EPS and outlook

Medtronic, Inc. (MDT) PT Raised to $94 at BMO Capital on 4Q Beat; 'Strength Across Franchises'

May 26, 2017 10:28 AM EDT

BMO Capital raised its price target on Medtronic, Inc. (NYSE: MDT) to $94.00 (from $87.00) while maintaining a Outperform rating, following the company's fourth quarter earnings report.

Analyst Joanne Wuensch notes the company delivered fourth quarter earnings per share and revenues above consensus expectations, as... More

Medtronic, Inc. (MDT) PT Raised to $93 at Oppenheimer Following 4Q

May 26, 2017 9:52 AM EDT

Oppenheimer raised its price target on Medtronic, Inc. (NYSE: MDT) to $93.00 (from $87.00) while maintaining a Outperform rating. MDT beat 4Q EPS by $0.02, led by higher constant-currency sales and gross margin along with lower FX headwind to EPS, somewhat offset by higher interest... More

Medtronic, Inc. (MDT) PT Raised to $94 at Barclays; Reiterates Overweight

May 26, 2017 7:59 AM EDT

Barclays raised its price target on Medtronic, Inc. (NYSE: MDT) to $94.00 (from $92.00) while maintaining a Overweight... More

Medtronic, Inc. (MDT) PT Raised to $91 at Evercore ISI on Strong 4Q EPS/Revenue Results; 'Gross Margin Beat Despite Mix Shift'

May 25, 2017 11:28 AM EDT

Evercore ISI raised its price target on Medtronic, Inc. (NYSE: MDT) to $91.00 (from $88.50) while maintaining a Outperform rating, following the company's fourth quarter earnings report.

Analyst Vijay Kumar notes the company delivered fourth quarter earnings per share and revenues above consensus projections, as... More